Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyethylene Glycols | 11 | 2021 | 149 | 1.280 |
Why?
|
| Drug Carriers | 9 | 2017 | 90 | 0.870 |
Why?
|
| Nanoparticles | 3 | 2021 | 254 | 0.820 |
Why?
|
| Nanocomposites | 1 | 2021 | 13 | 0.780 |
Why?
|
| Cellulose | 1 | 2021 | 22 | 0.760 |
Why?
|
| Membranes, Artificial | 1 | 2021 | 88 | 0.740 |
Why?
|
| Polymers | 8 | 2021 | 244 | 0.630 |
Why?
|
| Polyesters | 10 | 2013 | 55 | 0.620 |
Why?
|
| Micelles | 9 | 2013 | 43 | 0.570 |
Why?
|
| Soybean Proteins | 1 | 2016 | 11 | 0.570 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2016 | 7 | 0.560 |
Why?
|
| Drug Delivery Systems | 8 | 2017 | 236 | 0.540 |
Why?
|
| Tensile Strength | 2 | 2021 | 90 | 0.330 |
Why?
|
| Doxorubicin | 6 | 2015 | 231 | 0.320 |
Why?
|
| Molecular Structure | 6 | 2021 | 397 | 0.280 |
Why?
|
| Nanostructures | 3 | 2015 | 112 | 0.270 |
Why?
|
| Biosensing Techniques | 2 | 2021 | 51 | 0.270 |
Why?
|
| Cell Proliferation | 4 | 2015 | 1174 | 0.200 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 1070 | 0.200 |
Why?
|
| Polyvinyl Alcohol | 1 | 2021 | 8 | 0.200 |
Why?
|
| Elastic Modulus | 1 | 2021 | 25 | 0.200 |
Why?
|
| Biocompatible Materials | 4 | 2012 | 247 | 0.190 |
Why?
|
| Graphite | 1 | 2021 | 46 | 0.190 |
Why?
|
| Indoles | 1 | 2021 | 146 | 0.180 |
Why?
|
| Glucose | 1 | 2021 | 307 | 0.170 |
Why?
|
| Tissue Scaffolds | 2 | 2012 | 111 | 0.170 |
Why?
|
| Water | 3 | 2016 | 230 | 0.170 |
Why?
|
| Permeability | 2 | 2016 | 131 | 0.160 |
Why?
|
| Galantamine | 1 | 2017 | 9 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 45 | 0.150 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2017 | 58 | 0.150 |
Why?
|
| Folic Acid | 4 | 2010 | 123 | 0.150 |
Why?
|
| Metal Nanoparticles | 3 | 2021 | 88 | 0.140 |
Why?
|
| Steam | 1 | 2016 | 5 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2015 | 1851 | 0.120 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 35 | 0.120 |
Why?
|
| Polyamines | 1 | 2015 | 79 | 0.120 |
Why?
|
| Adventitia | 1 | 2014 | 2 | 0.120 |
Why?
|
| Octreotide | 1 | 2013 | 21 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2014 | 110 | 0.110 |
Why?
|
| Stilbenes | 1 | 2013 | 57 | 0.110 |
Why?
|
| Aptamers, Nucleotide | 1 | 2013 | 15 | 0.110 |
Why?
|
| Sirolimus | 1 | 2014 | 118 | 0.110 |
Why?
|
| Particle Size | 4 | 2017 | 201 | 0.100 |
Why?
|
| Durapatite | 1 | 2012 | 33 | 0.100 |
Why?
|
| Gold | 2 | 2009 | 76 | 0.100 |
Why?
|
| Materials Testing | 5 | 2012 | 263 | 0.100 |
Why?
|
| Tissue Engineering | 2 | 2012 | 212 | 0.100 |
Why?
|
| Hydrazones | 1 | 2009 | 11 | 0.090 |
Why?
|
| Plant Gums | 1 | 2009 | 2 | 0.090 |
Why?
|
| Galactans | 1 | 2009 | 2 | 0.090 |
Why?
|
| Mannans | 1 | 2009 | 3 | 0.090 |
Why?
|
| Photochemical Processes | 1 | 2009 | 10 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 81 | 0.080 |
Why?
|
| Methacrylates | 1 | 2009 | 31 | 0.080 |
Why?
|
| Urease | 1 | 2009 | 5 | 0.080 |
Why?
|
| Dendrimers | 1 | 2009 | 12 | 0.080 |
Why?
|
| Urea | 1 | 2009 | 51 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2013 | 618 | 0.080 |
Why?
|
| Hydrogels | 1 | 2009 | 54 | 0.080 |
Why?
|
| Cell Survival | 4 | 2014 | 901 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 95 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2009 | 109 | 0.080 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 101 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 2176 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 778 | 0.070 |
Why?
|
| Electrochemical Techniques | 2 | 2021 | 23 | 0.070 |
Why?
|
| Molecular Weight | 3 | 2013 | 358 | 0.070 |
Why?
|
| Electrodes | 2 | 2021 | 147 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2010 | 127 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2017 | 282 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2009 | 85 | 0.060 |
Why?
|
| Mice | 5 | 2017 | 8474 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2015 | 111 | 0.050 |
Why?
|
| Samarium | 1 | 2021 | 1 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2021 | 11 | 0.050 |
Why?
|
| Bioelectric Energy Sources | 1 | 2021 | 8 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 420 | 0.050 |
Why?
|
| Catalysis | 1 | 2021 | 123 | 0.050 |
Why?
|
| Oxides | 1 | 2021 | 47 | 0.050 |
Why?
|
| Static Electricity | 1 | 2021 | 91 | 0.050 |
Why?
|
| Animals | 6 | 2017 | 20881 | 0.050 |
Why?
|
| Adsorption | 1 | 2021 | 225 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 567 | 0.040 |
Why?
|
| Cell Line | 2 | 2017 | 1752 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2013 | 346 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1536 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1745 | 0.040 |
Why?
|
| Neoplasms | 1 | 2009 | 1667 | 0.040 |
Why?
|
| Polyglactin 910 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Drug Liberation | 1 | 2017 | 17 | 0.040 |
Why?
|
| Rats | 2 | 2017 | 5300 | 0.040 |
Why?
|
| Maze Learning | 1 | 2017 | 138 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2017 | 791 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2673 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Humans | 8 | 2015 | 68618 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2014 | 17 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2014 | 89 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 2013 | 10 | 0.030 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2013 | 13 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2013 | 19 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 144 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 294 | 0.030 |
Why?
|
| Porosity | 1 | 2012 | 63 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 329 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 317 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2012 | 136 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 312 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 508 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 65 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 337 | 0.020 |
Why?
|
| Viscosity | 1 | 2009 | 72 | 0.020 |
Why?
|
| Hematoxylin | 1 | 2009 | 8 | 0.020 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2009 | 8 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2009 | 30 | 0.020 |
Why?
|
| Enzymes, Immobilized | 1 | 2009 | 11 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2009 | 79 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 489 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2009 | 30 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 85 | 0.020 |
Why?
|
| Endocytosis | 1 | 2009 | 113 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 2083 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 363 | 0.020 |
Why?
|
| Solutions | 1 | 2009 | 115 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 104 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2009 | 130 | 0.020 |
Why?
|
| Light | 1 | 2009 | 152 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1047 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1641 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2009 | 384 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1753 | 0.020 |
Why?
|
| Male | 2 | 2014 | 37321 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 4655 | 0.010 |
Why?
|
| Female | 1 | 2009 | 38074 | 0.000 |
Why?
|